CIK 0001281895 · Non-accelerated filer<br>Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $405,500
- in 5 filings
Net −$405,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-06 | Rizvi Syed Ali-aamir Chief Medical Officer | Grant or award | +62,893 | 345,911 | ||
| 2025-10-06 | Rizvi Syed Ali-aamir Chief Medical Officer | Grant or award · Stock Option (right to buy) | +383,854 | 383,854 | ||
| 2025-09-24 | Fong Peter Director | Grant or award | +23,333 | 23,333 | ||
| 2025-09-24 | Fong Peter Director | Grant or award | +30,000 | 53,333 | ||
| 2025-09-19 | RTW INVESTMENTS, LP Director | Option exercise | +1,000,000 | $40.03 | $40.0M | 19,188,457 |
| 2025-09-19 | RTW INVESTMENTS, LP Director | Other disposition | −1,000,000 | $3.11 | $3.1M | 18,188,457 |
| 2025-09-19 | RTW INVESTMENTS, LP Director | Option exercise | +41,000 | $19.09 | $783K | 18,229,457 |
| 2025-09-19 | RTW INVESTMENTS, LP Director | Other disposition | −41,000 | $3.11 | $127K | 18,188,457 |
| 2025-09-19 | RTW INVESTMENTS, LP Director | Option exercise | +59,000 | $17.81 | $1.1M | 18,247,457 |
| 2025-09-19 | RTW INVESTMENTS, LP Director | Other disposition | −59,000 | $3.11 | $183K | 18,188,457 |
| 2025-09-19 | RTW INVESTMENTS, LP Director | Option exercise · Equity Swap (obligation to buy) | −1 | 0 | ||
| 2025-09-19 | RTW INVESTMENTS, LP Director | Option exercise · Equity Swap (obligation to buy) | −1 | 0 | ||
| 2025-09-19 | RTW INVESTMENTS, LP Director | Option exercise · Equity Swap (obligation to buy) | −1 | 0 | ||
| 2025-09-08 | Militello John See Remarks | Grant or award | +40,000 | 95,924 | ||
| 2025-09-08 | Wilson Martin General Counsel | Grant or award | +150,000 | 285,462 | ||
| 2025-09-08 | Schwartz Jonathan David See Remarks | Grant or award | +80,000 | 301,609 | ||
| 2025-08-27 | Bjork Elisabeth Director | Purchase | +10,000 | $3.41 | $34K | 40,000 |
| 2025-08-19 | Militello John See Remarks | Sale | −361 | $3.00 | $1K | 55,924 |
| 2025-08-19 | Schwartz Jonathan David See Remarks | Sale | −805 | $3.00 | $2K | 221,609 |
| 2025-08-19 | Wilson Martin General Counsel | Sale | −588 | $3.00 | $2K | 135,462 |
Page 5 of 9 · 164 trades